| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  miRecule, Inc. RNA Therapeutics We develop first-in-class RNA-based therapies, with lead programs in Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD). Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics – the right drug for the right patient. Our proprietary DREAmiRTM platform utilizes genomic and outcome data from thousands of patients to identify underlying genetic changes that cause their disease, and then creates a novel RNA therapeutic that can directly target and fix that genetic abnormality. Type: | 2 | 2 | 1 | 19 |
 | Jazz Pharmaceuticals Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has a significant corporate presence in Palo Alto, CA and Philadelphia, PA … Type: | 13 | 3 | 1 | 3,385 |
 | Amgen Foundation Everyone needs science. Science needs everyone. Since 1991, the Foundation has contributed more than $450M overall, with over $270M going towards science education. We are committed to inspiring the next generation of scientists and future problem solvers - wherever they are. Type: | 11 | 1 | 3 | 10 |
 | Codexis, Inc. We deliver exquisite enzymes for the betterment of human health. Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic … Type: | 10 | 0 | 9 | 249 |
 | PharmaVentures The Deal Experts PharmaVentures is a premier transaction advisory firm and a leading international company in partnering, M&A deals and strategic alliances. For over 30 years, PharmaVentures has acted as advisor on over 1,000 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide. PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes it uniquely placed to support business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest. … Type: | 13 | 0 | 11 | 34 |
 | MPM BioImpact Building Companies to Transform Patient Outcomes MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients’ lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies. Cancer Therapy, Disease Treatment, Funding companies to make a difference, Pharmaceuticals, Investment, Biotech, Venture Creation, and Therapeutics Type: | 8 | 2 | 5 | 58 |
 |  Mintu Turakhia, MD MS Chief Medical & Scientific Officer @irhythmtech. Co-founder https://t.co/gkWDOD6hia. Professor @Stanford @StanfordCDH. EP, scientist, trialist, builder. Views mine. Type: | 22 | 1 | 21 | N/A |
 | Plexus Ventures LLC Plexus Ventures is a prominent healthcare advisory boutique. Our team of professionals are located in markets all over the world – the United States, Europe, and the Asia-Pacific market, including China and Japan – enabling us to combine local knowledge with global reach. pharmaceutical, drug delivery, biotechnology, consumer & OTC, business development & consulting, out-licensing, in-licensing, divestments, acquisitions, global pharmaceutical market experts, marketing & sales, project management, biosimilars, medical device, and consultants Type: | 38 | 0 | 38 | 16 |
 | Domain Associates ABOUT Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on investing in life science companies that advance human health. Domain’s focused network, deep experience, and dependable reputation of this team have made it one of the top private-equity groups participating in healthcare investing. With $2.4 billion of capital under management, Domain invests in three major segments: pharmaceuticals, diagnostics, and medical devices. EXPERIENCE Domain has raised eight funds and has been involved in the formation of more than 250 portfolio companies. The partners of Domain have a total of close to 200 person-years of … Type: | 7 | 0 | 7 | 21 |
 | mAbxience From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South … Type: | 6 | 2 | 3 | 984 |
 | SPAG, A FINN Partners Company Award-winning PR & Advocacy firm | APAC | Integrated Communications | Healthcare, Tech, Development, Start-ups, Food & Nutrition | A @FINNPartners Company Type: | 20 | 0 | 20 | N/A |
 | PTC Therapeutics, Inc. We're committed to a single purpose: Extending life’s moments for patients with rare diseases and their loved ones. PTC is a patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for children and adults living with rare and serious disease. Orphan and Ultra-orphan Disorders, Oncology, and Anti-infectives Type: | 13 | 1 | 7 | 1,142 |
 | CSL Behring Biotherapies & Rare Disease CSL Behring, a Business Unit of CSL, is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders. The company’s products are also used in cardiac surgery, burn treatment and to prevent hemolytic disease of the newborn. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL;USOTC:CSLLY), headquartered in Melbourne, Australia, employs more … Type: | 1 | 1 | 0 | 7,600 |
 | HealthBeacon Smart Tools for Managing Medication HealthBeacon is a medical adherence technology company. We develop smart tools for managing medication. Type: | 21 | 4 | 15 | 44 |
 | European Society for Paediatric Infectious Diseases - ESPID ESPID's mission is to promote excellence in paediatric infectious diseases and child health. ESPID promotes the exchange of information among people who have special experience in the field of paediatric infectious diseases (by organizing regular scientific meetings, forming international study groups and networks, participation in advisory boards of other societies, organization of symposia at other international congresses, and through joint publications by members’ publications in the Pediatric Infectious Diseases Journal and other journals) ESPID supports the formation and function of independent units (e.g. sections, departments, divisions) in order to encourage progress in the field of infectious diseases in childhood. (as … Type: | 6 | 3 | 2 | 11 |
 | Centers for Disease Control and Prevention CDC works 24/7 keeping America safe from health, safety and security threats, both foreign and domestic. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights it and supports communities and citizens to prevent it. CDC is the nation’s health protection agency - saving lives, protecting people from health threats, and saving money through prevention. For more information, please go to: http://www.cdc.gov/ Comment Policy: Please visit http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html to view CDC’s social media comment policy. Privacy Notice Regarding Third Party Websites: Privacy Notice: The Centers for Disease Control and Prevention … Type: | 73 | 26 | 19 | 21,375 |
 | PA Consulting PA. Bringing Ingenuity to Life We believe in the power of ingenuity to build a positive human future. As strategies, technologies, and innovation collide, we create opportunity from complexity. Our diverse teams of experts combine innovative thinking and breakthrough technologies to progress further, faster. Our clients adapt and transform, and together we achieve enduring results. We are over 4,000 strategists, innovators, designers, consultants, digital experts, scientists, engineers, and technologists. And we have deep expertise in consumer and manufacturing, defence and security, energy and utilities, financial services, government and public services, health and life sciences, and transport. Our teams operate globally … Type: | 41 | 5 | 25 | 5,163 |
 | Sagard Europe Sagard is an alternative asset management firm that invests in venture capital, private equity, private credit, real estate, and royalties. We invest in Europe through two private equity strategies. Sagard Midcap invests in middle-market business services, healthcare, food & consumer, and industrial sectors in Europe. Learn more at sagard.com/midcap Sagard NewGen supports entrepreneurs in the technology and healthcare industries to accelerate their growth projects in Europe and beyond. Learn more at sagard.com/newgen Type: | 8 | 3 | 4 | 391 |
 | Arrowhead Pharmaceuticals At Arrowhead Pharmaceuticals we are breaking the mold of medicine. We are pushing the boundaries of therapeutic development and revolutionizing how we care for hard-to-treat illnesses. As a company we harness collaboration and innovation to rapidly advance drugs from discovery to the clinic. All applicants: Please be aware of employment scams using Arrowhead’s name and the names of Arrowhead’s employees. All job related Arrowhead communication should come from the domain @arrowheadpharma.com. Biotech, Drug Development, Pharmaceuticals, and RNAi Type: | 3 | 1 | 1 | 556 |
 | Devicare The Digital Therapeutic Company in Urology Devicare is a specialty biotech company dedicated to develop pathbreaking medical treatments in Urology combining the most recent scientific advances in nutritional therapy with digital technologies. Biotechnology, Medical devices , Digital Health , eHealth, Healthcare, and Digital Therapeutics Type: | 7 | 0 | 4 | 24 |
 | Nimbus Therapeutics Applying deep computational chemistry expertise to create novel small molecule therapeutics. At Nimbus, we design breakthrough medicines. Utilizing our powerful structure-based drug discovery engine, we create potent and selective small molecule compounds targeting proteins that are known to be fundamental drivers of pathology in highly prevalent human diseases and which have proven difficult for other drug makers to tackle. With a decade-plus track record of success, we’ve built a world-class team in both computationally driven drug discovery and early clinical development while continuing to move the needle for patients. computational chemistry, biochemistry, small molecule therapeutics, oncology, immunology, metabolism, and drug … Type: | 8 | 1 | 6 | 104 |
 | RiverVest Venture Partners A leading venture capital firm building life science companies to address significant unmet medical needs RiverVest Venture Partners® is a leading venture capital firm building life science companies to address significant unmet needs of patients and deliver consistently strong returns to investors. With headquarters in St. Louis and offices in San Diego and Cleveland, RiverVest accesses forward-thinking research and clinical expertise at leading institutions across the country to found and fund biopharma and medical device companies. Entrepreneurs turn to RiverVest for the scientific, operational, financial, and investment expertise they need to achieve long-term success. RiverVest is committed to doing business … Type: | 4 | 1 | 2 | 16 |
 | Allogene Therapeutics Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR TTM) products for cancer and autoimmune disease. For additional information on our guidelines, please visit www.allogene.com/news-center#community-guidelines Please be aware that the FBI recently issued a warning about an increased number of fake job postings for remote work employment that target applicants' personally identifiable information. All approved Allogene Therapeutics positions are accessible via the Allogene Careers page at www.allogene.com/careers. oncology, cancer, biotechnology, immunotherapy, CAR T, and autoimmune Type: | 6 | 3 | 3 | 281 |
 | Sage Therapeutics Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more … Type: | 8 | 2 | 4 | 621 |
 | Surgeon General [Automatic translation follows] ONLY INTERESTED IN INVESTOR ROUND THE WORLD TO CONTACT ME AND TO BE MY FRIEND,, BECAUSE HERE FOR IMPORTANT BUSINESS SURGEON, SPECIALIST IN ANY TYPE OF DISEASE, HUMBLE AND HONEST DOCTOR WHO IS READY TO FLY AROUND THE WORLD JUST TO CARE FOR HUMANITY Type: | 52 | 24 | 20 | 171 |
 | Seagen Seagen is now part of Pfizer! Together with our Pfizer colleagues, we will continue our mission of bringing life-saving treatments to people living with cancer. Our scientific leadership and world-leading antibody-drug conjugate (ADC) technology combined with the scale and strength of Pfizer's capabilities and expertise, will help position Pfizer at the forefront of innovation in cancer care. We are so proud of our employees for the work that has been done over the past 25 years to positively impact the cancer community. Check out the announcement https://lnkd.in/dfq7V-tw to join us in our excitement for the future. Seagen social media accounts, … Type: | 9 | 3 | 5 | 1,387 |
 | Jason Lotkowictz Husband to @lcrampsie | Father to @drizzlife and Scarlett | Sr. Director Industry Sales @InStepHealth the leader in #SmarterPOC and end-to-end Rx marketing! | 12 | 0 | 12 | N/A |
 | Sarepta Therapeutics Dragging Tomorrow Into Today. Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a global biotechnology company on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For information on our Community Guidelines, please visit sarepta.com/community-guidelines. We want to share a reminder with all job seekers and candidates … Type: | 14 | 3 | 4 | 1,469 |
 | Eli Lilly and Company We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center … Type: | 104 | 25 | 48 | 45,821 |
 | City of Hope City of Hope's mission is to deliver the cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center at its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research … Type: | 26 | 6 | 16 | 11,133 |
 | Caris Life Sciences Fulfilling the promise of precision medicine through quality and innovation. Caris Life Sciences® (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation … Type: | 1 | 1 | 0 | 1,430 |
 | This Is Money The aim of thisismoney.co.uk is to win justice for its 3m-plus readers - and arm them with the best possible financial advice and information, empowering them to make the right choices. This is Money's editorial team has also built a reputation for fighting for readers' individual rights, intervening where necessary and winning dozens of individual victories. Type: | 39 | 10 | 8 | 19 |
 | Wave Life Sciences Unlocking the broad potential of RNA medicines to transform human health Wave Life Sciences is a biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health. Our RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation and deep insights in human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Our toolkit of RNA-targeting modalities includes editing, splicing, RNA interference and antisense silencing, providing us with unmatched capabilities for designing and sustainably delivering candidates that optimally address disease biology. Our diversified pipeline includes clinical programs in Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency … Type: | 7 | 4 | 4 | 335 |
 | Basilea Pharmaceutica For the benefit of patients Basilea is a commercial-stage biopharmaceutical company founded in 2000 and headquartered in the heart of the life sciences hub of Basel area, Switzerland. We are committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections. We have successfully launched two hospital brands: Cresemba for the treatment of invasive fungal infections and Zevtera for the treatment of severe bacterial infections. In addition, we have several preclinical anti-infective assets in our portfolio. Basilea currently has about 150 employees and is listed on the SIX Swiss Exchange (SIX: … Type: | 1 | 1 | 0 | 211 |
 | Grifols Innovating for patients and society Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, … Type: | 3 | 2 | 1 | 11,261 |
 | Eisai US Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: https://bit.ly/3dkY At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related … Type: | 23 | 5 | 14 | 2,921 |
 | Evoke MicroMass Evoke MicroMass is now Inizio Evoke Drive, a global marketing agency that delivers full service creative capabilities to accelerate brands, businesses and patient experiences by delivering unmatched results for clients across every therapeutic area. Proudly part of Inizio Evoke, a global health marketing, communications, and transformation platform unlocking growth through data-driven insights and human centricity. We are purpose-built to make Health more humanTM. Follow Inizio Evoke to stay up-to-date with news, insights, and career opportunities from Inizio Evoke Drive. Marketing Agency, Behavioral Marketing, Digital Agency, CRM Agency, Communication Planning, RM Agency, Healthcare Relationship Marketing, Behavioral Research, Consulting, Creative, Full-Service, and … Type: | 6 | 2 | 2 | 130 |
 | Cytokinetics Empowering Muscle Empowering Lives Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in … Type: | 6 | 1 | 4 | 518 |
 | Vane Percy & Roberts Vane Percy & Roberts is a healthcare and science communications consultancy led by two partners, Simon Vane Percy and Sarah Roberts. All accounts are directed by Simon or Sarah and supported by the very experienced VPR team. This hands-on approach which gives all clients access to the senior team members is relatively unique in PR. It is, however, what makes us stand out from the crowd and successful in what we do. We have worked for a wide variety of clients spanning a number of sectors. However, we focus on activities which achieve positive results rather than offering an ‘off … Type: | 1 | 0 | 1 | 10 |
 | Pharma Marketing Network Fostering a collaborative community environment for the pharmaceutical and healthcare marketing ecosystem. More than 20 years ago, John Mack created The Pharma Marketing Network® at www.Pharma-Mkting.com and became a social media brand as "PharmaGuy". When John retired in 2018, R.J. Lewis was passed the baton and relaunched the site in March of 2019 with an impressive industry advisory board. The Pharma Marketing Network® (PMN) is now an open, collaborative community environment for the pharmaceutical and healthcare marketing ecosystem. The PMN is designed to understand the challenges and trends of today, while collaborating with industry professionals, thought leaders, and visionaries to … | 20 | 0 | 18 | 11 |
 | Bausch Health Companies Inc. Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company that develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 7,000 employees are united around our mission of improving people’s lives with our health care products, and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars, or guiding principles, represent the foundation on which we are realizing our mission … Type: | 7 | 1 | 0 | 2,599 |
 | Merck At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and … Type: | 19 | 17 | 0 | 42,027 |
 | Ashfield Event Experiences We are now Emota We are now Emota Meeting planners, Event production, Live events, Pharmaceutical meetings, Event communication, Incentives, Event management, Conferences, Sales conferences, Investigator meetings, Product launches, Creative development, and Exhibition services Type: | 11 | 1 | 9 | 165 |
 | Evaluate Ltd Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry Evaluate provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global pharmaceutical market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action: Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. EvaluatePharma - the trusted global view of the … Type: | 28 | 2 | 26 | 187 |
 |  Zealand Pharma Changing lives with next generation peptide therapeutics Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a Danish biotechnology company on a mission to change lives with next generation peptide medicines. In our effort to reach our goals bonding is at the core of everything we do. Let it be discovering and developing the best new peptide drugs for patients, engaging with partners or connecting with each other. This has led to more than 10 drug candidates invented by Zealand having advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on … Type: | 6 | 3 | 2 | 336 |
 | uniQure Transforming the lives of patients through gene therapy uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases. aav and lpl Type: | 2 | 2 | 0 | 430 |
 | WE Communications Deutschland [Automatic translation follows] We believe in the power of communication that motivates people to take positive action. #WeAreWE For our team of analysts and geeks, communication challenges and special tasks are the greatest: We work with enthusiasm and a strategically clear head - and without compromising on quality. Our customers value us as part of their team - a pleasant surprise. We love what we do, because many can do "simple". #WeareWE We let our customers shine. As a partner at your side, we have your back. Everything we do is geared towards your success. Our approach is analytical, strategic … Type: | 14 | 0 | 15 | 34 |
 | Swelife [Automatic translation follows] Together we create sustainable growth - for the individual's health. Swelife wants to strengthen life science in Sweden and improve public health. Swelife works to increase cohesion and efficiency in the health and life science sectors in Sweden, in order to create growth and better public health. Swelife is a strategic innovation program that is financed by Vinnova and the project's partners. We want to make it possible for skills and resources to be used in the best way. We do this through national cooperation and coordination. We want to reduce the fragmentation within life science in … Type: | 12 | 3 | 10 | 20 |
 | National Institute of Biomedical Imaging and Bioengineering (NIBIB) Engineering the future of health The National Institute of Biomedical Imaging and Bioengineering is one of 27 Institutes and Centers that comprise the National Institutes of Health (NIH). NIBIB synthesizes the best ideas from the diverse fields of science and engineering to improve human health. Visit us at http://www.nibib.nih.gov This is the official LinkedIn account of NIBIB. Our comment policy, privacy policy, and related notices are posted at http://www.nibib.nih.gov/policies Engagement ≠ endorsement For general information about NIBIB, send us an email at info@nibib.nih.gov Type: | 4 | 2 | 2 | 99 |
 | Bausch + Lomb We're a leading global eye health organization that is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Our comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, we have a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Eye health, ophthalmic pharmaceuticals, ophthalmic surgical products, and contact lens … Type: | 21 | 8 | 4 | 8,853 |
 | Alnylam Pharmaceuticals Alnylam is the leading RNAi therapeutics company. We're a fast-growing biopharma with a deep pipeline and global reach. ALNYLAM IS LEADING THE RNAi REVOLUTIONTM Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s … Type: | 34 | 7 | 19 | 2,322 |
 | European Medicines Agency The mission of EMA is to foster scientific excellence in the evaluation and supervision of medicines in the EU. The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. Type: | 41 | 23 | 3 | 1,544 |
 | MR SOLUTIONS GROUP. Magnetic resonance and molecular imaging MR SOLUTIONS is a world leader in MRI technology (www.mrsolutions.com) We are a leading developer and manufacturer of the world’s first range of commercial, preclinical, cryogen-free, benchtop MRI systems (0.01T - 9.4T). Dry Magnets. We are the world’s largest, independent developer and manufacturer of MRI spectrometers for use by manufacturers of Clinical MRI systems and for upgrading any MRI scanner. MR SOLUTIONS, which is head quartered in the UK, is a world leader in the development and manufacture of MRI systems and components including; The world’s first range of commercial, ultra compact, cryogen free, 0.10T … Type: | 4 | 0 | 0 | 43 |
 | Merck KGaA, Darmstadt, Germany We are Merck KGaA, Darmstadt, Germany and its global affiliates. We are a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a … Type: | 3 | 3 | 1 | 13,318 |
 | Media Affairs MediaAffairs entwickelt Wissen über Medienmärkte. Damit unterscheidet sich das Unternehmen wesentlich von konventionellen Anbietern aus dem Bereich der Medien(resonanz)analyse, die – auf gänzlich andere Art und Weise – Daten über Unternehmen, Personen, Themen usw. sammeln und als Informationen über das mediale Geschehen an ihre Kunden übermitteln. Auch MediaAffairs analysiert Medien, erarbeitet Statistiken über Präsenz, Themenführerschaft u.v.m. Darüber hinaus aber kennen wir die Medienmärkte, die wir im Auftrag unserer Kunden beschreiben. Daraus ergibt sich eine einzigartige Expertise unserer Mitarbeiter, mit der diese jede Information über das mediale Geschehen anreichern. Dies ist eine der wesentlichen Voraussetzungen, die uns für den professionellen Dialog … Type: | 91 | 52 | 1 | 16,540 |
Startup